KSI-201

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug NameKSI-201

Drug Alias NameKSI-201

ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Antibody conjugate > Monoclonal antibody conjugateBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Monoclonal antibody conjugate

Mechanisms of ActionUpdating

TargetsUpdating

Therapy Area/IndicationsWet age-related macular degeneration

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPending (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesKodiak Sciences Inc

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesKodiak Sciences Inc

Active IndicationsN/A

Inactive IndicationsWet age-related macular degeneration

Other Information

ATC CodeN/A